(Total Views: 467)
Posted On: 10/29/2025 10:07:12 AM
Post# of 158777
Dr. J's drive on PD-L1 data.
*2020 mTNBC trial protocol observed PD-L1
*13D SEC filing was related to ICI's
*Very bottom of our 2022 corp presentation mentions Upregulating
2024, we had no results. Dr. J just said in Rx video --- he asked to be CEO & goal was to ascertain how long patients lived, so he could report. Amarex was not forthcoming with -- Follow-up data.
That statement makes you now realize -- "Upregulating" closure is why Dr. J became CEO.
It drove him crazy for humanity & without him....no historical LL story.
*2020 mTNBC trial protocol observed PD-L1
*13D SEC filing was related to ICI's
*Very bottom of our 2022 corp presentation mentions Upregulating
2024, we had no results. Dr. J just said in Rx video --- he asked to be CEO & goal was to ascertain how long patients lived, so he could report. Amarex was not forthcoming with -- Follow-up data.
That statement makes you now realize -- "Upregulating" closure is why Dr. J became CEO.
It drove him crazy for humanity & without him....no historical LL story.
(2)
(0)
